GALT

Galectin Therapeutics INC

-$8.2M

Net Activity

Institutions Holding

100

Popularity Rank

#4442

Avg Weight

0.01%

Total Value

$43.0M

Ownership Trend

100 institutions currently hold GALT, with 50 net buyers and 40 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

40

Net Buying Institutions

50

Key Holders

View all 100 holding institutions

Quarterly Activity

Recent Activity

+$30.1M

Total Buy Value

$11.4M

Total Sell Value

New buy17
Trim24
Add33
Sold out16

50

Net Buyers

40

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

4

Filings (90d)

$518K

Total Est. Value

106K shares

Planned Shares

Last Filed 2026-06-29
FilerFiling DateEst. Value
Shlevin Harold H.2026-06-29$112K
Jamil Khurram2026-06-26$341K
Shlevin Harold H.2026-06-26$39K
Jamil Khurram2026-06-23$26K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding GALECTIN THERAPEUTICS INC (GALT)?
Major stakeholders currently include Vanguard Capital Management LLC ($5.5M), Marshall Wace, LLP ($3.4M), Osaic Holdings, INC. ($3.1M). Based on the latest 13F filings, there are a total of 100 tracked investment funds and institutions maintaining positions in GALT.
What is the overall institutional sentiment toward GALT recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $8.2M, driven by 50 managers accumulating shares while 40 reduced their exposure.
Which institutions have been selling or reducing their GALT positions?
In the latest period, 24 funds trimmed their holdings, and 16 managers completely exited their positions. The aggregate reported sell value was $11.4M.
Are there any notable investors adding GALT to their portfolios?
Yes, buying activity remains notable. 17 institutions opened new positions in {ticker}, and 33 existing holders added to their shares. The total reported buy value for the quarter amounted to $30.1M.

Related Stocks